Natixis’s Ventyx Biosciences VTYX Stock Holding History

Natixis’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-75,000	Closed	-$185K	–	1250
2023 Q4	$185K	Buy	+75,000	New	+$712K	﹤0.01%	723

Other funds holding VTYX

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Natixis's VTYX Position: Q1 2024 in Review

Natixis sold out of Ventyx Biosciences (VTYX) in Q1 2024, closing a stake of 75,000 shares — an estimated $185K sold.

Natixis first reported a position in VTYX in Q4 2023 and held it in 1 quarter. The position peaked at $185K in Q4 2023. 126 funds tracked by Wall St. Rank hold VTYX as of Q1 2024.

Natixis reported no remaining Ventyx Biosciences position as of Q1 2024 after selling out during the quarter.
Natixis sold 75,000 Ventyx Biosciences shares in Q1 2024, an estimated $185K.
Natixis first reported a position in Ventyx Biosciences in Q4 2023 and held it in 1 quarter.
Natixis's Ventyx Biosciences position peaked at $185K in Q4 2023.
126 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2024.

Based on Natixis's 13F filing for Q1 2024, filed 13 May 2024.